In the Boardroom
Refine Search
Biosimilars
IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, has announced that Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers, is taking over the position of IGBA chairman for 2020 from Jim Keon, president of the Canadian Generic Pharmaceutical Association and Biosimilars Canada. 10 January 2020
Biotechnology
Sweden-based CNS specialist AlzeCure Pharma has appointed Martin Jönsson as its new chief executive with effect on January 9. 8 January 2020
Pharmaceutical
Ahead of completing its $63 billion buy of Ireland-incorporated Allergan, AbbVie today announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. 8 January 2020
Biotechnology
US biotech firm FibroGen has appointed Enrique Conterno as the company’s chief executive and a member of the board of directors, effective immediately. 7 January 2020
Pharmaceutical
Mene Pangalos, one of the leaders behind AstraZeneca’s remarkable recent record of successful drug development, has been awarded a knighthood. 31 December 2019
Biotechnology
US cell and gene therapy company Abeona Therapeutics saw its shares gain 4.2% to $3.75 in after-hours trading Tuesday, after it announced that the European Medicines Agency has granted the designation of Priority Medicines ( PRIME) for its ABO-102, which studies its punctual gene therapy based on adeno-associated virus 9 (AAV9) for the treatment of Sanfilippo syndrome type A (MPS IIIA). 27 December 2019
Biotechnology
Oslo-based biotech Zelluna Immunotherapy has appointed Namir Hassan as chief executive officer, replacing Miguel Forte. 19 December 2019
Biotechnology
In a surprise move, Ipsen chief executive David Meek has quit his position at the French drugmaker to take the helm at a small gene therapy startup, FerGene. 18 December 2019
Pharmaceutical
Katy Wallace, principal consultant in the Life Sciences Practice at executive search firm, Berwick Partners, explains why the pharma industry needs diverse leadership in an Expert View piece. 10 December 2019
Pharmaceutical
US drugmaker Eli Lilly appears to have been so impressed with its newly-acquired subsidiary Loxo Oncology that it has asked it to take over the running of its oncology R&D. 5 December 2019
Pharmaceutical
A US Senate panel has all but confirmed that Stephen Hahn will be the next Commissioner of the Food and Drug Administration (FDA). 4 December 2019
Biotechnology
India's Biocon, Asia's premier biotechnology company, has named Siddharth Mittal as its new chief executive and joint managing director. 3 December 2019
Biotechnology
Vancouver, Canada-based regenerative medicine company NervGen Pharma announced the appointment of Paul Brennan as president and chief executive effective immediately. 28 November 2019
Pharmaceutical
Germany-headquartered central nervous system (CNS) specialist Neuraxpharm Group today announced the expansion of its operations in Southern Europe with the launch of Neuraxpharm Portugal. 28 November 2019
Pharmaceutical
The Office of Women’s Health (OWH), part of the US Food and Drug has announced the selection of Kaveeta Vasisht as the Associate Commissioner for Women’s Health. 27 November 2019
Biotechnology
Kite Pharma, which was acquired in 2017 by Gilead Sciences in a transaction valued at around $12 billion, announced two new additions to the company’s leadership team. 22 November 2019
Pharmaceutical
Vifor Pharma today announced the appointment of Lee Heeson as president international and a member of the executive committee as of February 1, 2020, with the news sending the Swiss drugmaker’s shares up 2.37% to 161.85 francs. 18 November 2019
Pharmaceutical
A little over five years ago, British drugmaker GlaxoSmithKline was riding high, following multiple years of strong sales and related year-on-year share price gains. 15 November 2019
Generics
US healthcare and medical devices company Abbott today announced that Miles White will be stepping down as chief executive on March 31, 2020, after a remarkable 21-year tenure, the second longest for a non-founder in today's S&P 100, according to the company. 13 November 2019
Generics
Shares in Teva Pharmaceutical Industries were up by 11% after 100 minutes of New York trading on Thursday, following the company’s presentation of its third-quarter financial results. 7 November 2019
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze